Drug Search Results
More Filters [+]

Fomepizole

Alternative Names: fomepizole, 4-methylpyrazole, antizol
Latest Update: 2024-03-04
Latest Update Note: Clinical Trial Update

Product Description

an inhibitor of alcohol dehydrogenase. Fomepizole appears to be safe and effective in the treatment of methanol poisoning. (Sourced from: https://www.nejm.org/doi/full/10.1056/nejm200102083440605)

Mechanisms of Action: ADH Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Austria | Belgium | Canada | Czech | Finland | France | Germany | Greece | Iceland | India | Ireland | Japan | Malta | Netherlands | New Zealand | Norway | Slovenia | Sweden | Taiwan | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fomepizole

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Chemical and Drug Induced Liver Injury|Drug Overdose|Liver Failure

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT05517668

P2

Recruiting

Chemical and Drug Induced Liver Injury|Liver Failure|Drug Overdose

2025-08-31

Recent News Events